STRO-002 – Patient Worthy

Sourced from Pixabay

Phase 1 Clinical Data on STRO-002 Shows Promise for Treating Ovarian Cancer

Post author:Jessica Lynn
Post published:May 12, 2020
Post category:Ovarian Cancer

According to a press release from PR Newswire and GuruFocus, drug discovery and development company Sutro Biopharma received promising phase 1 clinical data for their drug therapy STRO-002. Their Phase…

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.

Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Keep Up to Date

Learn More